{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ENDOCRINE THERAPY" , "@language" : "en" } ,        { "@value" : "Hormon\u00E1ln\u00ED l\u00E9\u010Diva pou\u017E\u00EDvan\u00E1 v onkologii" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antagonist\u00E9 hormon\u016F a p\u0159\u00EDbuzn\u00E1 l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "HORMONE ANTAGONISTS AND RELATED AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02BG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Enzymov\u00E9 inhibitory" , "@language" : "cs" } ,        { "@value" : "Enzyme inhibitors" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02BG" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L02BG04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L02" ,        "http://linked.opendata.cz/resource/ATC/L02B" ,        "http://linked.opendata.cz/resource/ATC/L02BG" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Letrozol" , "@language" : "cs" } ,        { "@value" : "Letrozole" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L02BG04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184835",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Letrozole" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/ETRUZIL-2-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0184835" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127966" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127965" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127964" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127963" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127967" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127960" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127959" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127961" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127962" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127967",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 100X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127960",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "28" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 28X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127966",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "98" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 98X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127965",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 13174.08984375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 6838.43994140625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 90X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127964",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "84" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 84X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127963",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "60" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 60X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127959",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 10X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127961",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 4676.7998046875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 2279.47998046875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 30X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127962",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "ETRUZIL 2,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L02BG04" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC95447_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Adjuvantn\u00ED l\u00E9\u010Dba \u017Een v postmenopauze s\u00A0\u010Dasn\u00FDm st\u00E1diem karcinomu prsu s\u00A0pozitivn\u00EDmi hormon\u00E1ln\u00EDmi receptory.\nProdlou\u017Een\u00E1 adjuvantn\u00ED l\u00E9\u010Dba \u010Dasn\u00E9ho st\u00E1dia hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze, kter\u00E9 prod\u011Blaly p\u0159edchoz\u00ED p\u011Btiletou standardn\u00ED adjuvantn\u00ED terapii tamoxifenem.\nPrvn\u00ED linie l\u00E9\u010Dby pokro\u010Dil\u00E9ho hormon-dependentn\u00EDho karcinomu prsu u \u017Een v postmenopauze.\nPokro\u010Dil\u00FD karcinom prsu u \u017Een s\u00A0p\u0159irozen\u00FDm nebo um\u011Ble vyvolan\u00FDm postmenopauz\u00E1ln\u00EDm stavem po relapsu nebo p\u0159i progresi onemocn\u011Bn\u00ED, kter\u00E9 byly ji\u017E p\u0159edt\u00EDm l\u00E9\u010Deny antiestrogeny.\nU pacientek s\u00A0 karcinomem prsu bez pozitivn\u00EDho n\u00E1lezu hormon\u00E1ln\u00EDch receptor\u016F nebyla \u00FA\u010Dinnost prok\u00E1z\u00E1na.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 50X2.5MG" , "@language" : "cs" } ] }] }